BCR-ABL transcript variant's significance in chronic myeloid leukemia in chronic phase: Institutional experience from a developing country

被引：0
|
作者：
Prasad, S. K. [1 ]
Chennamaneni, R. [1 ]
Stalin, B. [1 ]
Konatam, M. L. [1 ]
Gundeti, S. [1 ]
机构：
[1] Nizams Inst Med Sci, Med Oncol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1099P
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [31] BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
    Loscocco, Federica
    Visani, Giuseppe
    Galimberti, Sara
    Curti, Antonio
    Isidori, Alessandro
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [32] BCR-ABL BREAKPOINT AND PROGNOSIS IN CHRONIC MYELOID-LEUKEMIA
    BACCARANI, M
    SAGLIO, G
    ZACCARIA, A
    TURA, S
    BLOOD, 1992, 79 (09) : 2499 - 2500
  • [33] Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia
    Gregor, T.
    Rynes, J.
    Foldynova-Trantirkova, S.
    Mayer, J.
    Krejci, P.
    Trantirek, L.
    FEBS JOURNAL, 2017, 284 : 286 - 286
  • [34] Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg
    Pagnano, Katia B. B.
    Miranda, Eliana Cristina Martins
    Delamain, Marcia T.
    Duarte, Gislaine Oliveira
    De Paula, Erich Vinicius
    Povoa, Valquiria
    Vergilio, Bruna Rocha
    Lorand-Metze, Irene
    De Souza, Carmino Antonio
    BLOOD, 2016, 128 (22)
  • [35] Impact of BCR-ABL mutations on patients with chronic myeloid leukemia
    Hochhaus, Andreas
    La Rosee, Paul
    Mueller, Martin C.
    Ernst, Thomas
    Cross, Nicholas C. P.
    CELL CYCLE, 2011, 10 (02) : 250 - 260
  • [36] INHIBITION OF APOPTOSIS BY BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
    BEDI, A
    ZEHNBAUER, BA
    BARBER, JP
    SHARKIS, SJ
    JONES, RJ
    BLOOD, 1994, 83 (08) : 2038 - 2044
  • [37] ALTERNATIVE 5' END OF THE BCR-ABL TRANSCRIPT IN CHRONIC MYELOGENOUS LEUKEMIA
    ROMERO, P
    BERAN, M
    SHTALRID, M
    ANDERSSON, B
    TALPAZ, M
    BLICK, M
    ONCOGENE, 1989, 4 (01) : 93 - 98
  • [38] Prognostic Significance of Transcript-Type BCR-ABL1 in Chronic Myeloid Leukemia
    Molica, Matteo
    Abruzzese, Elisabetta
    Breccia, Massimo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [39] Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant
    Qin, Ya Zhen
    Jiang, Bin
    Jiang, Qian
    Zhang, Yan
    Jiang, Hao
    Li, Jin Lan
    Zhu, Hong Hu
    Li, Ling Di
    Liu, Yan Rong
    Chen, Shan Shan
    Huang, Xiao Jun
    ACTA HAEMATOLOGICA, 2008, 120 (03) : 146 - 149
  • [40] Characterization of Bcr-Abl deletion mutants from patients with chronic myeloid leukemia
    Sherbenou, Daniel W.
    Hantschel, Oliver J.
    Turaga, Lalita
    Kaupe, Ines
    Willis, Stephanie
    Bumm, Thomas
    Press, Richard D.
    Superti-Furga, Giulio
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2007, 110 (11) : 862A - 863A
12345